[Prognosis of patients with recurrence after curative resection of advanced gastric cancer].

Zhonghua Wei Chang Wai Ke Za Zhi

Department of Gastric Cancer, Cancer Institute and Hospital, Tianjin Medical University, Tianjin 300060, China.

Published: February 2011

Objective: To investigate the clinical features and prognosis of recurrent gastric cancer.

Methods: Clinical data of 163 patients with recurrent gastric cancer from Jan. 2001 to Jan. 2005 were reviewed. Patients were compared between those with and without symptoms.

Results: Seventy-two patients(44.2%) were symptomatic, while 91(55.8%) were asymptomatic. There were significant differences in lymph node metastasis between the two groups(P<0.05). The median overall survival was significantly longer in asymptomatic patients (19.8 vs. 15.7 months, P<0.05). Post-recurrence survival was also longer in the asymptomatic group (9.5 vs. 4.8 months, P<0.01). The median recurrence-free interval in asymptomatic patients was 10.0 months, which was significantly longer than that in the symptomatic patients (9.2 months, P<0.05). On univariate survival analysis,post-gastrectomy chemotherapy (P<0.05), symptoms of recurrence(P<0.01), TNM staging(P<0.01), recurrence-free interval (P<0.01), and reoperation(P<0.01) were associated with the prognosis. On multivariable analysis, TNM staging(P<0.01), symptoms of recurrence(P<0.01), recurrence-free interval (P<0.05), and reoperation(P<0.05) were independent risk factors.

Conclusions: Patients with recurrent gastric cancer have poor prognosis. Close monitoring and active follow-up of patients with gastric cancer should be conducted during the first two years after operation. Reoperation may improve survival in patients with recurrent gastric cancer.

Download full-text PDF

Source

Publication Analysis

Top Keywords

recurrent gastric
8
[prognosis patients
4
patients recurrence
4
recurrence curative
4
curative resection
4
resection advanced
4
advanced gastric
4
gastric cancer]
4
cancer] objective
4
objective investigate
4

Similar Publications

Background: Surgical fundoplication remains integral in managing gastroesophageal reflux disease (GERD) by addressing gastroesophageal valve incompetence. This study introduces a novel hybrid approach, the Eversion Cruroplasty and Collar Overwrap (ECCO) procedure, aiming to combine benefits of conventional partial wrapping and posteromedial cardiopexy, considering gastric fundus anatomical peculiarities as an anti-reflux barrier.

Methods: A retrospective analysis of pediatric patients presenting with refractory GERD from 2021 to 2023 was conducted.

View Article and Find Full Text PDF

Background: Adolescents and young adults (AYA) with germline CDH1 variants are at risk of overtreatment when precancer lesions are detected with endoscopic screening. We characterize diffuse-type gastric cancer prevalence and survival in AYA managed with prophylactic total gastrectomy (PTG) or endoscopic surveillance.

Methods: Prospective cohort study of 188 individuals aged 39 and younger enrolled from January 27, 2017, to May 1, 2023.

View Article and Find Full Text PDF

Aim: To compare minimally invasive and open surgery for older patients with gastric cancer.

Methods: This study included 464 consecutive patients with gastric cancer aged ≥75 years who underwent open or laparoscopic gastrectomy at our institution from January 2004 to December 2018. We performed propensity score-matching and compared short- and long-term outcomes between the two groups.

View Article and Find Full Text PDF
Article Synopsis
  • Sarcoidosis is a multisystem disease that commonly affects African American women and people of Scandinavian descent, characterized by noncaseating granulomas.
  • A 29-year-old African American male presented with recurrent symptoms related to gallstones, specifically right upper quadrant pain after eating, and was found to have cholelithiasis on imaging.
  • During an elective surgery for gallbladder removal, liver lesions were discovered, and a biopsy revealed noncaseating granulomas consistent with sarcoidosis, indicating an unusual manifestation of the disease in the liver and lymph nodes.
View Article and Find Full Text PDF

Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd).

Gastroenterol Hepatol

January 2025

Servicio de Hepatología, Hospital Clínic, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, España. Electronic address:

Portal hypertension is a hemodynamic abnormality that complicates the course of cirrhosis, as well as other diseases that affect the portal venous circulation. The development of portal hypertension compromises prognosis, especially when it rises above a certain threshold known as clinically significant portal hypertension (CSPH). In the consensus conference on Portal Hypertension promoted by the Spanish Association for the Study of the Liver and the Hepatic and Digestive diseases area of the Biomedical Research Networking Center (CIBERehd), different aspects of the diagnosis and treatment of portal hypertension caused by cirrhosis or other diseases were discussed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!